LCFA/IASLC Translational Thoracic Oncology Research Grants
This grant funds early-career researchers advancing translational research in lung cancer detection, diagnosis, and patient care, with a focus on clinically impactful and patient-centered projects.
Funder: International Association for the Study of Lung Cancer
Due Dates (Anticipated): October 2026 (Letter of Intent) | January 2027 (Full application)
Funding Amounts: $100,000/year for up to 2 years (total up to $200,000); no indirect costs; max 50% of budget for salary/fringe.
Summary: Supports early-career investigators advancing translational research in lung cancer detection, diagnosis, and care.
Key Information: Applications are projected to open October 2026; eligibility restrictions apply for seniority and prior funding.
Description
The LCFA/IASLC Translational Thoracic Oncology Research Grants, offered jointly by the Lung Cancer Foundation of America and the International Association for the Study of Lung Cancer, are designed to accelerate innovative translational research in lung cancer. These grants specifically support early-career investigators working on projects that improve detection, diagnosis, and patient care, with the broader aim of reducing the burden of lung cancers. Projects with potential for near-term clinical impact, especially those that may lead to or incorporate prospective clinical trials, are highly encouraged. Additional consideration is given to proposals that address access to care, benefit underrepresented populations, or have the potential to rapidly improve patient outcomes.
